Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
In an earlier version of this article, we inaccurately described the change to the Lovenox (enoxaparin) prescribing information. The revisions to the prescribing information regarding prosthetic heart ...
It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...
Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
PARIS, May 18 (Reuters) - Sanofi-Aventis has won U.S. health authority clearance to use its bloodthinner Lovenox in patients who suffer from the most severe type of heart attack, the French drugmaker ...
Sound the alarm on Lovenox--generic competition is coming. The Sanofi-Aventis (NYSE: SNY) blood thinner will see its first copycat rival now that Sandoz, the generics arm of Novartis, has won FDA ...
LONDON (Reuters) - Bayer AG has launched its new anticoagulant pill Xarelto in Britain and Germany, pricing the product on a par with Sanofi-Aventis's Lovenox injection, the company said on Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback